Terms: = Thyroid cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Treatment
69 results:
1. cancer-associated fibroblast-derived periostin promotes papillary thyroid tumor growth through integrin-FAK-stat3 signaling.
Jin X; Deng Q; Ye S; Liu S; Fu Y; Liu Y; Wu G; Ouyang G; Wu T
Theranostics; 2024; 14(7):3014-3028. PubMed ID: 38773979
[No Abstract] [Full Text] [Related]
2. Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11.
Wang Z; Zong H; Liu W; Lin W; Sun A; Ding Z; Chen X; Wan X; Liu Y; Hu Z; Zhang H; Li H; Liu Y; Li D; Zhang S; Zha X
J Exp Clin Cancer Res; 2024 Apr; 43(1):112. PubMed ID: 38610018
[TBL] [Abstract] [Full Text] [Related]
3. K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor immunotherapy in triple-negative breast cancer.
Wang X; Deng X; Hu J; Zheng W; Ye D; Zhou X; Fang L
Cancer Lett; 2024 Apr; 588():216764. PubMed ID: 38431034
[TBL] [Abstract] [Full Text] [Related]
4. IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/stat3 pathway.
Zhou M; Yu H; Bai M; Lu S; Wang C; Ke S; Huang J; Li Z; Xu Y; Yin B; Li X; Feng Z; Fu Y; Jiang H; Ma Y
Cancer Sci; 2024 Mar; 115(3):777-790. PubMed ID: 38228495
[TBL] [Abstract] [Full Text] [Related]
5. Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma.
Afaq F; Agarwal S; Bajpai P; Diffalha SA; Kim HG; Peter S; Khushman M; Chauhan SC; Mukherjee P; Varambally S; Manne U
Neoplasia; 2024 Jan; 47():100951. PubMed ID: 38039923
[TBL] [Abstract] [Full Text] [Related]
6. Oncogenic PIK3CA recruits myeloid-derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5-lipoxygenase-dependent arachidonic acid pathway.
Li X; Chen G; Wang F; Guo X; Zhang R; Liu P; Dong L; Yu W; Wang H; Wang H; Yu J
Clin Transl Med; 2023 Nov; 13(11):e1483. PubMed ID: 37965796
[TBL] [Abstract] [Full Text] [Related]
7. Downregulation of cellular retinoic acid binding protein 1 fosters epithelial-mesenchymal transition in thyroid cancer.
Hsu YC; Huang WC; Kuo CY; Li YS; Cheng SP
Mol Carcinog; 2023 Dec; 62(12):1935-1946. PubMed ID: 37642311
[TBL] [Abstract] [Full Text] [Related]
8. [Clinicopathological features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma].
Zhu M; Li J; Zheng WH; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):820-826. PubMed ID: 37527987
[No Abstract] [Full Text] [Related]
9. stat3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
[TBL] [Abstract] [Full Text] [Related]
10. Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells.
Zhang GQ; Xi C; Shen CT; Song HJ; Luo QY; Qiu ZL
Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37260320
[TBL] [Abstract] [Full Text] [Related]
11. Inhibition of ALK-Signaling Overcomes STRN-ALK-Induced Downregulation of the Sodium Iodine Symporter and Restores Radioiodine Uptake in thyroid Cells.
Nikitski AV; Condello V; Divakaran SS; Nikiforov YE
Thyroid; 2023 Apr; 33(4):464-473. PubMed ID: 36585857
[No Abstract] [Full Text] [Related]
12. Dual Inhibition of BRAF-MAPK and stat3 Signaling Pathways in Resveratrol-Suppressed Anaplastic thyroid cancer Cells with BRAF Mutations.
Lu MD; Li H; Nie JH; Li S; Ye HS; Li TT; Wu ML; Liu J
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430869
[TBL] [Abstract] [Full Text] [Related]
13. TRIB3 Interacts with stat3 to Promote cancer Angiogenesis.
Chen QZ; Chen Y; Li X; Liu H; Sun XL
Curr Med Sci; 2022 Oct; 42(5):932-940. PubMed ID: 36245025
[TBL] [Abstract] [Full Text] [Related]
14. Integrated analysis of novel macrophage related signature in anaplastic thyroid cancer.
Luo Y; Yang YC; Ma B; Xu WB; Liao T; Wang Y
Endocrine; 2022 Dec; 78(3):517-530. PubMed ID: 36070052
[TBL] [Abstract] [Full Text] [Related]
15. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2/stat3 signaling.
Liu W; Wang X; Wang L; Mei Y; Yun Y; Yao X; Chen Q; Zhou J; Kou B
Int J Med Sci; 2022; 19(6):965-974. PubMed ID: 35813296
[TBL] [Abstract] [Full Text] [Related]
16. HMGN4 plays a key role in stat3-mediated oncogenesis of triple-negative breast cancer.
Mou J; Xu X; Wang F; Kong W; Chen J; Ren J
Carcinogenesis; 2022 Oct; 43(9):874-884. PubMed ID: 35792800
[TBL] [Abstract] [Full Text] [Related]
17. GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/stat3 pathways in anaplastic thyroid carcinoma.
Gao H; Wang W; Li Q
Cancer Biol Ther; 2022 Dec; 23(1):369-377. PubMed ID: 35491899
[TBL] [Abstract] [Full Text] [Related]
18. DCZ0415, a small-molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4/stat3 axis and the Wnt/β-catenin pathway in colorectal cancer.
Agarwal S; Afaq F; Bajpai P; Kim HG; Elkholy A; Behring M; Chandrashekar DS; Diffalha SA; Khushman M; Sugandha SP; Varambally S; Manne U
Mol Oncol; 2022 Apr; 16(8):1728-1745. PubMed ID: 35194944
[TBL] [Abstract] [Full Text] [Related]
19. Indoleamine 2,3-dioxygenase 1 regulates breast cancer tamoxifen resistance through interleukin-6/signal transducer and activator of transcription.
Zhao X; Jiang Y; Xu M; Hu J; Feng N; Deng H; Lu C; Huang T
Toxicol Appl Pharmacol; 2022 Apr; 440():115921. PubMed ID: 35157906
[TBL] [Abstract] [Full Text] [Related]
20. LncRNA ABHD11-AS1 promotes tumor progression in papillary thyroid carcinoma by regulating EPS15L1/EGFR signaling pathway.
Lu H; Zhu C; Chen Y; Ruan Y; Fan L; Chen Q; Wei Q
Clin Transl Oncol; 2022 Jun; 24(6):1124-1133. PubMed ID: 35098448
[TBL] [Abstract] [Full Text] [Related]
[Next]